A61P 25/20
Hypnotics
Official title: Hypnotics; Sedatives
A61P25/20 (Hypnotics) appears on 6,467 US grants and 8,057 published applications in this corpus.
Search patents in A61P- Granted patents
- 6,467
- Published applications
- 8,057
- Assignees
- 2,142
- Inventors
- 13,502
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 24 | 0 |
| 1977 | 30 | 0 |
| 1978 | 29 | 0 |
| 1979 | 29 | 0 |
| 1980 | 32 | 0 |
| 1981 | 40 | 0 |
| 1982 | 34 | 0 |
| 1983 | 28 | 0 |
| 1984 | 42 | 0 |
| 1985 | 41 | 0 |
| 1986 | 32 | 0 |
| 1987 | 37 | 0 |
| 1988 | 61 | 0 |
| 1989 | 62 | 0 |
| 1990 | 64 | 0 |
| 1991 | 60 | 0 |
| 1992 | 59 | 0 |
| 1993 | 67 | 0 |
| 1994 | 80 | 0 |
| 1995 | 77 | 0 |
| 1996 | 100 | 0 |
| 1997 | 176 | 0 |
| 1998 | 121 | 0 |
| 1999 | 99 | 0 |
| 2000 | 85 | 0 |
| 2001 | 114 | 30 |
| 2002 | 144 | 181 |
| 2003 | 140 | 304 |
| 2004 | 131 | 423 |
| 2005 | 121 | 375 |
| 2006 | 196 | 425 |
| 2007 | 172 | 435 |
| 2008 | 206 | 486 |
| 2009 | 244 | 569 |
| 2010 | 302 | 633 |
| 2011 | 298 | 495 |
| 2012 | 365 | 463 |
| 2013 | 331 | 343 |
| 2014 | 339 | 340 |
| 2015 | 272 | 338 |
| 2016 | 206 | 326 |
| 2017 | 273 | 323 |
| 2018 | 214 | 235 |
| 2019 | 184 | 246 |
| 2020 | 167 | 222 |
| 2021 | 146 | 191 |
| 2022 | 89 | 142 |
| 2023 | 87 | 153 |
| 2024 | 91 | 141 |
| 2025 | 76 | 146 |
| 2026 | 50 | 92 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin6 Oct 2026US 12,751,960 B2Compass Pathfinder Limited
- Anti-sleep disorder article29 Sep 2026US 12,746,147 B2Fine Cotton Factory Inc.
- Transmucosal film for treating insomnia15 Sep 2026US 12,734,127 B1Xiamen LP Pharmaceutical Co., Ltd.
- Treatment of CNS disorders with sleep disturbances25 Aug 2026US 12,714,683 B2University of Copenhagen
- Formulations of psilocybin and psilocin compounds as serotonin agonists in combination with 3,4 methylenedioxymethamphetamine (MDMA)18 Aug 2026US 12,708,635 B2Altrartis Therapeutics Inc.
- Use of reboxetine to treat narcolepsy8 Oct 2026US 2026/0306501 A1Axsome Therapeutics, Inc.
- Oxysterols and methods of use thereof8 Oct 2026US 2026/0308197 A1Sage Therapeutics, Inc.
- Sleep formulation1 Oct 2026US 2026/0294816 A1NightWise, LLC
- Use of reboxetine to treat narcolepsy1 Oct 2026US 2026/0294919 A1Axsome Therapeutics, Inc.
- Use of reboxetine to treat narcolepsy1 Oct 2026US 2026/0294920 A1Axsome Therapeutics, Inc.
Most cited
By later US patents
- Gum pad for delivery of medication to mucosal tissues1,140US 6,319,510 B12001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003
- Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents342US 6,309,663 B1Lipocine Inc. · 2001